Assessment of risk factors of treatment discontinuation among patients on paliperidone palmitate and risperidone microspheres in france, germany and belgium – a retrospective database study

INTRODUCTION: Long-acting antipsychotics (e.g. 1-monthly (PP1M) / 3-monthly (PP3M) injection forms of paliperidone palmitate) have been developed to improve treatment continuation in schizophrenia patients. OBJECTIVES: To assess risk factors of treatment discontinuation in patients on paliperidone p...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, R., Decuypere, F., Chevalier, P., Wimmer, A., Guillon, P., Pype, S., Godet, A., Timtschenko, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471791/
http://dx.doi.org/10.1192/j.eurpsy.2021.437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471791/
http://dx.doi.org/10.1192/j.eurpsy.2021.437

Ejemplares similares